L673-0135 Screening compound: 2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide

L673-0135 Screening compound: 2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide
L673-0135 Screening compound: 2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L673-0135
2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L673-0135

Molecular Formula

C27H29N3O4S (C27 H29 N3 O4 S)

Compound Name

2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide

IUPAC name

2-[4-(4-cyclohexylbenzenesulfonamido)phenoxy]-N-cyclopropylpyridine-3-carboxamide

SMILES

O=C(c1cccnc1Oc(cc1)ccc1NS(c1ccc(C2CCCCC2)cc1)(=O)=O)NC1CC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

491.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.049

Distribution Coefficient, logD

6.027

Water Solubility, LogSw

-5.76

Polar Surface Area

81.831

Acid Dissociation Constant (pKa)

8.67

Base Dissociation Constant (pKb)

0.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

L673-0135 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L673-0135 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L673-0135?
Check Price and Availability of L673-0135, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L673-0135 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L673-0135
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L673-0135
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L673-0135 available by request